Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Adp-Tilil7
Melanoma
Inge Marie SvaneP1CC (43)
Adu-1805
Clear Cell Renal Carcinoma
Sairopa B.V.P1CC (43)
Adxs-504
Prostate Cancer
Mark SteinP1CC (43)
Afp Specific T Cell Receptor T Cells
Hepatocellular Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd.P1CC (43)
ag-01 compound
Hormone-Resistant Breast Carcinoma
A&G Pharmaceutical Inc.P1CC (43)
ag-181
Phenylketonuria
Agios Pharmaceuticals, Inc.P1CC (43)
agx101
Angiosarcoma
Angiex, Inc.P1CC (43)
ai-061
Bile Duct Cancer
OncoC4, Inc.P1CC (43)
ai-061
Gastroesophageal Junction Adenocarcinoma
OncoC4, Inc.P1CC (43)
ai-061
Ovarian Serous Adenocarcinoma
OncoC4, Inc.P1CC (43)
AIR
Cluster Headache Syndrome
The University of Texas Health Science Center, HoustonP1CC (43)
AIR
Hemicrania Continua
The University of Texas Health Science Center, HoustonP1CC (43)
AIR
Paroxysmal Hemicrania
The University of Texas Health Science Center, HoustonP1CC (43)
AIR
SUNCT Syndrome
The University of Texas Health Science Center, HoustonP1CC (43)
AIR
Trigeminal Autonomic Cephalalgia
The University of Texas Health Science Center, HoustonP1CC (43)
Air-001
Alpha 1-Antitrypsin Deficiency
AIRNA CorporationP1CC (43)
Ajh-2947
Diabetic Neuropathy
JMackem Co., LtdP1CC (43)
Ajh-2947
Postherpetic Neuralgia
JMackem Co., LtdP1CC (43)
ak112
Pancreatic Ductal Adenocarcinoma
AkesoP1CC (43)
ak154
Pancreatic Ductal Adenocarcinoma
AkesoP1CC (43)
Akk
Radiodermatitis
West China HospitalP1CC (43)
Akkermansia Muciniphila
Metabolic Dysfunction-Associated Steatotic Liver Disease
Leeuwenhoek Laboratories Co. Ltd.P1CC (43)
Ala-101
Leukemia
Arovella Therapeutics LtdP1CC (43)
Ala-101
Non-Hodgkin Lymphoma
Arovella Therapeutics LtdP1CC (43)
Allo-316
Nonpapillary Renal Cell Carcinoma
Allogene TherapeuticsP1CC (43)
Showing 851 to 875 of 9,928 assets
PreviousPage 35 of 398Next